Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has The Induced Pluripotent Stem Cell (iPSC) Market Size Shifted, And What Is the Outlook Through 2034?

The market size for induced pluripotent stem cells (ipsc) has seen a sizable increase in the recent past. The forecast is that it will expand from $3.3 billion in 2024 to $3.67 billion in 2025, with a compound annual growth rate (CAGR) of 11.3%. The historical period’s growth is due to factors such as the increase in healthcare spend, boosted funding, increasing awareness of the medicinal potential of stem cell products, the use of IPSC based drug discovery, the rising demand for tailored medical treatments and the cost-effectiveness of IPSC in drug discovery.

The market for induced pluripotent stem cells (ipsc) is projected to experience a robust expansion in the years ahead, with its value estimated to reach$5.29 billion by 2029, reflecting a compound annual growth rate (CAGR) of 9.6%. This anticipated growth through the forecast period is primarily due to the escalating prevalence of chronic and genetic diseases, the proliferation of genomic projects, the creation of IPSC-derived disease models, governmental initiatives, and the swift advancement of technology. Key trends observed during the forecast period encompass the utilization of pluripotent stem cells in Parkinson’s disease (PD) research, forging strategic collaborations and partnerships, creation of induced pluripotent stem cell (IPSC)-derived nk cells and IPSC for cell therapy, increased investments in regenerative medicine R&D, development of an IPSC expansion medium, personalised IPSC production, and the application of pluripotent stem cells in researching type I diabetes.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2515&type=smp

What Are the Core Growth Drivers Propelling the Induced Pluripotent Stem Cell (iPSC) Market Forward?

The induced pluripotent stem cell market is experiencing growth due to an increased prevalence of chronic conditions. Diseases such as heart disease, stroke, cancer, and diabetes, among others, can be treated with induced pluripotent stem cells, which can be harvested from any tissue in a child or adult and genetically modified to behave like embryonic stem cells. As per the details presented by the Partnership to Fight Chronic Disorder (PFCD), about 45% of the 133 million Americans, are living with at least one chronic disease. Furthermore, they estimated that roughly 1.7 million, or 7 in 10 deaths, in the US could be attributed to chronic illnesses, which are controllable by employing induced pluripotent stem cell therapies. This surge in the prevalence of chronic diseases is fuelling the demand in the induced pluripotent stem cell treatment market.

What Segment Types Define the Induced Pluripotent Stem Cell (iPSC) Market Structure?

The induced pluripotent stem cell (ipsc)market covered in this report is segmented –

1) By Derived Cell Type: Hepatocytes, Fibroblasts, Keratinocytes, Amniotic Cells, Other Derived Cell Types

2) By Application: Academic Research, Drug Discovery And Toxicity Studies, Regenerative Medicine, Cell And Gene Therapy

3) By End-User: Hospitals, Research Laboratories

Subsegments:

1) By Hepatocytes: iPSC-Derived Liver Cells For Drug Toxicity Testing; Disease Modeling And Regenerative Therapies

2) By Fibroblasts: iPSC-Derived Skin Cells For Wound Healing And Tissue Repair; Fibroblast-Based Disease Research

3) By Keratinocytes: iPSC-Derived Skin Cells For Dermatological Research; Skin Regeneration Therapies

4) By Amniotic Cells: iPSC-Derived Cells For Prenatal Research; Amniotic Fluid-Based Regenerative Applications

5) By Other Derived Cell Types: Neurons For Neurological Disease Modeling; Cardiomyocytes For Heart Disease Studies; Endothelial Cells For Vascular Research

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=2515&type=smp

Which Geographic Areas Hold the Strongest Growth Potential in the Induced Pluripotent Stem Cell (iPSC) Market?

North America was the largest region in the induced pluripotent stem cell (IPSC) market in 2024. Western Europe was the second largest region in the global induced pluripotent stem cell (IPSC) market share. The regions covered in the induced pluripotent stem cell (IPSC) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Which Emerging Trends that Are Influencing theInduced Pluripotent Stem Cell (iPSC) Industry Evolution?

Firms in the Induced Pluripotent stem cell market are exploring strategic alliances and collaborations as a means to broaden their geographical reach and enhance their product range. To illustrate, Bristol Myers Squibb and Century Therapeutics collaboratively decided in January 2022, to focus on the development of IPSC-derived allogenic cell therapies for the treatment of acute myeloid leukemia and multiple myeloma. In addition, a strategic partnership was initiated in May 2022 between Evotec and Sernova to devise an IPSC-oriented beta cell replacement therapy for managing type 1 and type 2 diabetes.

View the full report here:

https://www.thebusinessresearchcompany.com/report/induced-pluripotent-stem-cell-global-market-report

What Is the Definition of the Induced Pluripotent Stem Cell (iPSC) Market?

Induced pluripotent stem cells are the regenerated form of stem cells, which are produced from an existing adult cell, such as from hepatocytes, fibroblasts, keratinocytes, and neurons. This process involves introducing specific genes that induce the cell to become pluripotent, meaning it can differentiate into any cell type in the body (e.g., heart, brain, liver cells).

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2515

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model